This paper reports the results of a systematic search that aimed to identify clinical practice guidelines (CPGs) relevant to the rehabilitation of people with osteoarthritis and presents the CPG recommendations and the current state of evidence available for the interventions in the CPGs. To read the full article, log in using your NHS OpenAthens details.
This article highlights practical considerations in the initiation, switching and discontinuation of biologics in the management of JIA. To read the full article, log in using your NHS OpenAthens details.
The aim of this study was to investigate whether adding pain neuroscience education (PNE) to a multimodal approach has additional benefits in patients with fibromyalgia (FM). To read the full article, log in using your NHS OpenAthens details.
The objective of this study was to assess the outcomes of oligo- and polyarticular JIA in adulthood as well as the progression to authentic rheumatoid arthritis (RA). To read the full article, log in using your NHS OpenAthens details.
The objective of this case series is to highlight the musculoskeletal features and the clinical course among children with haematological malignancies. To read the full article, log in using your NHS OpenAthens details.
This study was planned to evaluate the strength, proprioception, skill, coordination, and functional condition of the hand in individuals with psoriatic arthritis and to correlate disease activity with these parameters. To read the full article, log in using your NHS OpenAthens details.
The COVID-19 pandemic was associated with the emergence of a new disease resembling the Kawasaki disease (kDa). This work is a literature review of data focusing on the clinical and prognostic characteristics of the MIS-C, the links between Covid-19 and MIS-C, and current therapeutic recommendations. To read the full article, log in using your NHS OpenAthens details.
There is limited data to help clinicians select the most appropriate biologic therapy for PsA patients, including guidance for decisions on biologic therapy switching. In this review we will examine the current understanding of predictors of response to treatment. To read the full article, log in using your NHS OpenAthens details.
Aim: To summarise the effectiveness of organisational interventions on appropriate opioid prescribing for non-cancer pain upon hospital discharge. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
The objective of this systematic review was to evaluate the efficacy of immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) and to further assess whether response differs between CTD subtypes and clinical features. To read the full article, choose “Institutional Login” and search for “Midlands Partnership”.
Secukinumab, the first IL-17A inhibitor, is widely used to treat immune diseases, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. Here, we aimed to explore the clinical characteristics, outcomes, and time to onset of the four main toxicities of secukinumab, using post-marketing data. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
Rheumatoid arthritis (RA) and osteoarthritis (OA) both are chronic diseases affecting joints. There is a hypothesis that suppression of immune response vs collagen could be a therapeutic approach in RA and OA. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
Systemic lupus erythematosus (SLE) with severe coronary artery disease (CAD) is associated with increased mortality. This study aimed to assess the characteristics and risk factors of severe CAD in SLE. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
Since 2010, biological disease-modifying antirheumatic drugs (bDMARDs) have been the dominant mode of treatment for rheumatoid arthritis (RA). However, the safety of DMARDs, such as tumor necrosis factor inhibitors (TNFis) and Janus kinase inhibitors (JAKis), in treating patients with RA is a concern. We compared the safety outcomes of JAKis and TNFis in RA patients in clinical settings. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
This work aims to evaluate the peripheral nerves and muscle involvement after COVID-19 infection, in addition to studying the prevalence rate and risk factors of their affection. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
This guideline updates recommendations for prevention and treatment of glucocorticoid-induced osteoporosis (GIOP) for patients with rheumatic or nonrheumatic conditions receiving >3 months treatment with glucocorticoids (GCs) ≥2.5 mg daily. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
The current study aims to assess the efficacy of baricitinib in treating SLE patients. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
This population-based study investigated the incidence and factors associated with mental illness among patients with rheumatoid arthritis receiving b/tsDMARDs. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.
This study aims to evaluate the efficacy and acceptability of the novel electrical therapy on sleep disturbance in autoimmune rheumatism diseases patients and its effect on immunologic factors. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.